Zentalis Pharmaceuticals, Inc.

8-K Shareholder vote results Jun 18, 2026 8-K Director or officer change May 27, 2026 8-K Regulation FD disclosure; Other events May 21, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2026 8-K Regulation FD disclosure; Other events May 5, 2026 8-K Regulation FD disclosure Apr 17, 2026 8-K Regulation FD disclosure; Other events Apr 9, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Regulation FD disclosure; Other events Jan 9, 2026 8-K Director or officer change; Other events Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 10, 2025 8-K Director or officer change; Regulation FD disclosure Aug 26, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2025 8-K Shareholder vote results Jun 18, 2025 8-K Regulation FD disclosure Jun 2, 2025 8-K Regulation FD disclosure May 20, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Regulation FD disclosure Apr 28, 2025 8-K Results of operations (earnings release) Mar 26, 2025 10-K Fiscal year ended 2024-12-31 Mar 26, 2025 8-K Regulation FD disclosure Mar 17, 2025 8-K Regulation FD disclosure; Other events Jan 29, 2025 8-K Exit or disposal costs; Regulation FD disclosure; Other events Jan 28, 2025 8-K/A Director or officer change Dec 19, 2024 8-K Director or officer change; Regulation FD disclosure Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Regulation FD disclosure; Other events Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release) Aug 9, 2024 8-K Shareholder vote results Jun 21, 2024 8-K Regulation FD disclosure Jun 3, 2024 8-K Director or officer change May 29, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Director or officer change Apr 11, 2024